Contents
Recent Patents on CNS Drug Discovery (Discontinued), Volume 9 - Number 2
Patents on Potential Drugs to Treat Alzheimer’s Disease: Special Emphasis on Small Peptides
, 9(2): 71 - 75Pazhani Sundaram, Aravind K. Nambiar and Ranjini K. Sundaram
DOI: 10.2174/1574889809666140919123006
Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
, 9(2): 76 - 84Martina Iannaccone, Federica Titta, Enrica Serretiello, Marco Monfregola and Vittorio Gentile
DOI: 10.2174/1574889809666141111160124
Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
, 9(2): 85 - 100Carlo Matera and Ada M. Tata
DOI: 10.2174/1574889809666141120131238
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases
, 9(2): 101 - 109Federica Titta, Martina Iannaccone, Antonio Martin and Vittorio Gentile
DOI: 10.2174/1574889809666140613114850
Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
, 9(2): 110 - 121Kimberley Mander, Elizabeth Harford-Wright, Kate M. Lewis and Robert Vink
DOI: 10.2174/1574889809666141111142740
Recent Patents on Novel MCH1 Receptor Antagonists as Potential Anti-Obesity Drugs
, 9(2): 122 - 140Katalin K. Szalai, Gyula Beke, Janos Eles, Tamas Kitka, Peter Kovacs, Jozsef Nagy, Sandor Farkas and Andras Boros
DOI: 10.2174/1574889809666140613115426
Webmaster Contact: info@benthamscience.org